Table 2.
Demographic characteristics and genotypes of 17 subjects in the multiple-dose study of gliclazide MR
| Genotype | Genotype | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Subject | Age (years) | Weight (kg) | CYP2C9 | CYP2C19 | Subject | Age (years) | Weight (kg) | CYP2C9 | CYP2C19 |
| 1 | 20 | 60 | *1/*1 | *1/*1 | 10 | 21 | 68 | *1/*1 | *1/*2 |
| 2 | 21 | 63 | *1/*1 | *1/*1 | 11 | 22 | 57 | *1/*1 | *1/*2 |
| 3 | 23 | 68 | *1/*1 | *1/*1 | 12 | 20 | 66 | *1/*1 | *1/*2 |
| 4 | 21 | 65 | *1/*1 | *1/*1 | 13 | 21 | 57 | *1/*1 | *1/*3 |
| 5 | 22 | 62 | *1/*1 | *1/*1 | 14 | 21 | 57 | *1/*1 | *1/*3 |
| 6 | 20 | 74 | *1/*1 | *1/*2 | 15 | 21 | 65 | *1/*1 | *2/*2 |
| 7 | 26 | 70 | *1/*1 | *1/*2 | 16 | 23 | 70 | *1/*1 | *2/*2 |
| 8 | 22 | 65 | *1/*1 | *1/*2 | 17 | 19 | 67 | *1/*1 | *2/*3 |
| 9 | 22 | 70 | *1/*1 | *1/*2 | |||||